J Yang, JF Xu, S Liang - Critical Reviews in Microbiology, 2024 - Taylor & Francis
Pseudomonas aeruginosa, able to survive on the surfaces of medical devices, is a life- threatening pathogen that mainly leads to nosocomial infection especially in …
FM de Carvalho, TB Valiatti, FF Santos… - Microbiology …, 2022 - Am Soc Microbiol
The epidemiology of antimicrobial resistance (AMR) is complex, with multiple interfaces (human-animal-environment). In this context, One Health surveillance is essential for …
M López, B Rojo-Bezares, G Chichón, Y Sáenz - Antibiotics, 2022 - mdpi.com
Fluoroquinolone resistance and the associated genetic mechanisms were assessed by antimicrobial susceptibility and whole genome sequencing in 56 Pseudomonas aeruginosa …
Fluoroquinolones are widely used as an empirical therapy for pseudomonal ocular infections. Based on increasing reports on acquired fluoroquinolone resistance genes in …
HL Zubyk, GD Wright - Antimicrobial Agents and Chemotherapy, 2021 - Am Soc Microbiol
Enzyme-mediated antibiotic inactivation is a common mechanism of drug resistance in bacteria (1). The genes encoding these resistance proteins are frequently associated with …
Two novel bla DIM-1-or bla IMP-1-containing genomic islands (GIs) were discovered by whole-genome sequence analyses in four extensively drug-resistant (XDR) Pseudomonas …
A Saini, I Mani, MK Rawal, C Verma, V Singh… - … Genomic Islands in …, 2023 - Springer
Genomic islands (GEIs) play a vital role in the bacteria's evolutionary adaptation and pathogenicity. GEIs are the unusual region located in the bacterial genome acquired …
Z Zhu, H Yang, Z Yin, Y Jing, Y Zhao, H Fu, H Du… - Virulence, 2021 - Taylor & Francis
The quinolone resistance crpP genes can mediate decreased susceptibility to quinolones. However, diversification and prevalence of crpP genes and crpP-carrying integrative and …
L Bientz, U Guyet, J Guiraud, M Metifiot… - Journal of Global …, 2025 - Elsevier
Carbapenem-resistant Pseudomonas aeruginosa is a global public health concern. IMP-13 is a carbapenemase that was described for the first time in 2001 but is often underestimated …